Merck & Co., Inc. (MRK) operating KPIs
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)
Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%
Latest, Q2 2026
41,933
Period ended Jun 30, 2026
Change on a year earlier
-14.4%
48,993 in Q2 2025
History
68 quarters
Since Q4 2008
Sources
67
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Merck & Co., Inc. Stockholders' Equity ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 41,933 | -14.4% | Form 10-Q (filed 2026-08-07) ↗ |
| Q1 2026 | Mar 31, 2026 | 45,878 | -5.1% | Form 10-Q (filed 2026-05-04) ↗ |
| Q4 2025 | Dec 31, 2025 | 52,606 | +13.6% | Form 10-K (filed 2026-02-24) ↗ |
| Q3 2025 | Sep 30, 2025 | 51,850 | +16.5% | Form 10-Q (filed 2025-11-05) ↗ |
| Q2 2025 | Jun 30, 2025 | 48,993 | +12.4% | Form 10-Q (filed 2025-08-05) ↗ |
| Q1 2025 | Mar 31, 2025 | 48,335 | +19.7% | Form 10-Q (filed 2025-05-02) ↗ |
| Q4 2024 | Dec 31, 2024 | 46,313 | +23.2% | Form 10-K (filed 2025-02-25) ↗ |
| Q3 2024 | Sep 30, 2024 | 44,502 | +7.9% | Form 10-Q (filed 2024-11-06) ↗ |
| Q2 2024 | Jun 30, 2024 | 43,582 | +12.6% | Form 10-Q (filed 2024-08-05) ↗ |
| Q1 2024 | Mar 31, 2024 | 40,364 | -13.8% | Form 10-Q (filed 2024-05-03) ↗ |
| Q4 2023 | Dec 31, 2023 | 37,581 | -18.3% | Form 10-K (filed 2024-02-26) ↗ |
| Q3 2023 | Sep 30, 2023 | 41,246 | -7.2% | Form 10-Q (filed 2023-11-03) ↗ |
| Q2 2023 | Jun 30, 2023 | 38,693 | -10.5% | Form 10-Q (filed 2023-08-07) ↗ |
| Q1 2023 | Mar 31, 2023 | 46,834 | +14.6% | Form 10-Q (filed 2023-05-05) ↗ |
| Q4 2022 | Dec 31, 2022 | 45,991 | +20.4% | Form 10-K (filed 2023-02-24) ↗ |
| Q3 2022 | Sep 30, 2022 | 44,458 | +24.2% | Form 10-Q (filed 2022-11-03) ↗ |
| Q2 2022 | Jun 30, 2022 | 43,243 | +29.9% | Form 10-Q (filed 2022-08-05) ↗ |
| Q1 2022 | Mar 31, 2022 | 40,883 | +51.7% | Form 10-Q (filed 2022-05-05) ↗ |
| Q4 2021 | Dec 31, 2021 | 38,184 | +50.8% | Form 10-K (filed 2022-02-25) ↗ |
| Q3 2021 | Sep 30, 2021 | 35,794 | +22.6% | Form 10-Q (filed 2021-11-05) ↗ |
| Q2 2021 | Jun 30, 2021 | 33,294 | +20.4% | Form 10-Q (filed 2021-08-09) ↗ |
| Q1 2021 | Mar 31, 2021 | 26,945 | +2.8% | Form 10-Q (filed 2021-05-05) ↗ |
| Q4 2020 | Dec 31, 2020 | 25,317 | -2.3% | Form 10-K (filed 2021-02-25) ↗ |
| Q3 2020 | Sep 30, 2020 | 29,186 | +8.7% | Form 10-Q (filed 2020-11-05) ↗ |
| Q2 2020 | Jun 30, 2020 | 27,642 | 0.0% | Form 10-Q (filed 2020-08-05) ↗ |
| Q1 2020 | Mar 31, 2020 | 26,205 | -4.8% | Form 10-Q (filed 2020-05-06) ↗ |
| Q4 2019 | Dec 31, 2019 | 25,907 | -3.0% | Form 10-K (filed 2020-02-26) ↗ |
| Q3 2019 | Sep 30, 2019 | 26,838 | -17.2% | Form 10-Q (filed 2019-11-05) ↗ |
| Q2 2019 | Jun 30, 2019 | 27,635 | -15.0% | Form 10-Q (filed 2019-08-06) ↗ |
| Q1 2019 | Mar 31, 2019 | 27,539 | -18.2% | Form 10-Q (filed 2019-05-08) ↗ |
| Q4 2018 | Dec 31, 2018 | 26,701 | -22.2% | Form 10-K (filed 2019-02-27) ↗ |
| Q3 2018 | Sep 30, 2018 | 32,422 | -15.2% | Form 10-Q (filed 2018-11-06) ↗ |
| Q2 2018 | Jun 30, 2018 | 32,529 | -17.6% | Form 10-Q (filed 2018-08-07) ↗ |
| Q1 2018 | Mar 31, 2018 | 33,668 | -15.5% | Form 10-Q (filed 2018-05-08) ↗ |
| Q4 2017 | Dec 31, 2017 | 34,336 | -14.3% | Form 10-K (filed 2018-02-27) ↗ |
| Q3 2017 | Sep 30, 2017 | 38,248 | -12.6% | SEC Filing ↗ |
| Q2 2017 | Jun 30, 2017 | 39,463 | -9.0% | SEC Filing ↗ |
| Q1 2017 | Mar 31, 2017 | 39,837 | -9.1% | SEC Filing ↗ |
| Q4 2016 | Dec 31, 2016 | 40,088 | -10.3% | SEC Filing ↗ |
| Q3 2016 | Sep 30, 2016 | 43,744 | -4.0% | SEC Filing ↗ |
| Q2 2016 | Jun 30, 2016 | 43,357 | -6.7% | SEC Filing ↗ |
| Q1 2016 | Mar 31, 2016 | 43,806 | -8.3% | SEC Filing ↗ |
| Q4 2015 | Dec 31, 2015 | 44,676 | -8.2% | Form 10-K (filed 2016-02-26) ↗ |
| Q3 2015 | Sep 30, 2015 | 45,587 | +0.8% | Form 10-Q (filed 2015-11-05) ↗ |
| Q2 2015 | Jun 30, 2015 | 46,448 | -3.9% | Form 10-Q (filed 2015-08-06) ↗ |
| Q1 2015 | Mar 31, 2015 | 47,765 | -4.4% | Form 10-Q (filed 2015-05-07) ↗ |
| Q4 2014 | Dec 31, 2014 | 48,647 | -2.2% | Form 10-K (filed 2015-02-27) ↗ |
| Q3 2014 | Sep 30, 2014 | 45,224 | -4.6% | Form 10-Q (filed 2014-11-10) ↗ |
| Q2 2014 | Jun 30, 2014 | 48,358 | – | Form 10-Q (filed 2014-08-07) ↗ |
| Q1 2014 | Mar 31, 2014 | 49,975 | -5.8% | Form 10-Q (filed 2014-05-08) ↗ |
| Q4 2013 | Dec 31, 2013 | 49,765 | -6.1% | Form 10-K (filed 2014-02-27) ↗ |
| Q2 2013 | Sep 30, 2013 | 47,419 | -14.9% | Form 10-Q (filed 2013-11-07) ↗ |
| Q1 2013 | Mar 31, 2013 | 53,029 | -3.3% | Form 10-Q (filed 2013-05-09) ↗ |
| Q4 2012 | Dec 31, 2012 | 53,020 | -2.7% | Form 10-K (filed 2013-02-28) ↗ |
| Q3 2012 | Sep 30, 2012 | 55,747 | +1.1% | Form 10-Q (filed 2012-11-09) ↗ |
| Q2 2012 | Jun 30, 2012 | 55,194 | -0.5% | Form 10-Q (filed 2012-08-07) ↗ |
| Q1 2012 | Mar 31, 2012 | 54,860 | – | Form 10-Q (filed 2012-05-08) ↗ |
| Q4 2011 | Dec 31, 2011 | 54,517 | +0.3% | Form 10-K (filed 2012-02-28) ↗ |
| Q3 2011 | Sep 30, 2011 | 55,140 | -0.8% | Form 10-Q (filed 2011-11-08) ↗ |
| Q2 2011 | Jun 30, 2011 | 55,496 | +0.5% | Form 10-Q (filed 2011-08-08) ↗ |
| Q4 2010 | Dec 31, 2010 | 54,376 | -7.9% | Form 10-K (filed 2011-02-28) ↗ |
| Q3 2010 | Sep 30, 2010 | 55,593 | +331.0% | Form 10-Q (filed 2010-11-08) ↗ |
| Q2 2010 | Jun 30, 2010 | 55,232 | +358.9% | Form 10-Q (filed 2010-08-06) ↗ |
| Q1 2010 | Mar 31, 2010 | 57,878 | – | Form 10-Q (filed 2010-05-07) ↗ |
| Q4 2009 | Dec 31, 2009 | 59,058 | +214.8% | Form 10-K (filed 2010-03-01) ↗ |
| Q3 2009 | Sep 30, 2009 | 12,900 | – | Form 10-Q (filed 2009-10-29) ↗ |
| Q2 2009 | Jun 30, 2009 | 12,035 | – | Form 10-Q (filed 2009-07-24) ↗ |
| Q4 2008 | Dec 31, 2008 | 18,758 | – | Form 10-K (filed 2010-03-01) ↗ |
Cite this data
StockData. (2026). Merck Merck & Co., Inc. Stockholders' Equity ($M) ($M), quarterly Q4 2008–Q2 2026 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/db_bal_eq
See every metric in the Merck KPI table. Data updated Oct 26, 2026.